Article Listing - Aronex re-seeks approval for Atragen

PROFITS UP AT ITALIAN SORIN BIOMEDICA IN 1991

6 April 1992

Sorin Biomedica made net profits in 1991 of 12.3 billion lire ($9.9 billion), up from 11 billion lire in the...

GENENTECH REBUFFS ISIS-3 AND AWAITS GUSTO

6 April 1992

With the formal publication in The Lancet last week of the results of the ISIS-3 thrombolytic product trial, the major...

INDIAN IBUPROFEN CHARGE DROPPED

6 April 1992

The US Department of Commerce has ceased its activities relating to claims of dumping and subsidies concerning imports into...

CHUGAI'S EPOCH

6 April 1992

A small study of Chugai's Epoch (recombinant erythropoietin) has found that while giving EPO to patients receiving autologous blood donation...

NEW DIRECTOR AT WHO

6 April 1992

Lionel Brisson of France has been appointed as director of program development and monitoring in the Office of the Director-General...

MGI PHARMA'S SALAGEN

6 April 1992

MGI Pharma has gained orphan drug status from the US Food and Drug Administration for Salagen (pilocarpine), to treat dry...

PFIZER'S DIFLUCAN

6 April 1992

Prophylactic administration of Pfizer's Diflucan (fluconazole) to recipients of autologous bone marrow transplants reduces the incidence of both systemic and...

Mexican Health Ministry Merges

6 April 1992

In a major shake-up within the Mexican administration, the government is proposing to merge the Ministry of Health with the...

STOCK MARKET COMMENTARY: EUROPE

6 April 1992

EUROPE: saw most bourses weak at the start of the reporting period, but strengthen as time went on. By the...

NIGERIAN HEALTH SPENDING FOR 1992

6 April 1992

The federal government of Nigeria has announced a total figure for health care spending in 1992 of 192 million naira,...

Showing 94421-94430 of 95325 articles